PT - JOURNAL ARTICLE AU - Rebelo, João S. AU - Domingues, Célia P. F. AU - Dionisio, Francisco AU - Gomes, Manuel C. AU - Botelho, Ana AU - Nogueira, Teresa TI - COVID-19 lockdowns may reduce resistance genes diversity in the human microbiome and the need for antibiotics AID - 10.1101/2021.03.08.21253164 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.08.21253164 4099 - http://medrxiv.org/content/early/2021/03/12/2021.03.08.21253164.short 4100 - http://medrxiv.org/content/early/2021/03/12/2021.03.08.21253164.full AB - Recently, much attention has been paid to the COVID-19 pandemic, yet bacterial resistance to antibiotics remains a serious and unsolved public health problem, which kills thousands of people annually, being an insidious and silent pandemic. In this study, we explored the idea of confinement and the tightening of the hygiene measures to contain the spreading of coronavirus, to simulate the effect that it has on lowering the spreading of pathogenic bacteria in a human network, and on the need to use antibiotics. For that, we used computational biology to generate simulations.Competing Interest StatementThe authors have declared no competing interest.Funding Statement The authors received no specific funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No clinical trials have been performedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no new data generated